HealthStream, Inc. Form 8-K Summary
Business Context and Reporting Period
HealthStream, Inc. filed a Form 8-K reporting compensation actions approved by its Compensation Committee on September 18, 2026. The filing is not a quarterly or annual financial report and does not cover a financial reporting period.
Material Event and Compensation Arrangements
- The Committee approved special equity grants under the shareholder-approved 2022 Omnibus Incentive Plan to incentivize future performance and executive retention.
- Robert A. Frist, Jr., Michael M. Collier, Trisha L. Coady, and Kevin P. O’Hara each received 15,395 time-based restricted share units (RSUs), with a grant date fair value of $450,000 per executive.
- Scott A. Roberts received 12,316 time-based RSUs, with a grant date fair value of $360,000.
- The time-based RSUs vest in equal annual installments of 25% on each of the first four anniversaries of the grant date.
- Mr. Frist, Mr. Collier, Ms. Coady, and Mr. O’Hara each received 5,132 performance-based RSUs, with a grant date fair value of $150,000 per executive.
- Mr. Roberts received 4,105 performance-based RSUs, with a grant date fair value of $120,000.
- The performance-based RSUs are eligible to vest in equal 25% increments based on achievement of annual performance targets established by the Committee for 2027, 2028, 2029, and 2030.
Financial Metrics, Liquidity, and Outlook
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating and financial metrics. It also does not disclose the specific performance targets applicable to the performance-based RSUs.
Risks and Unusual Items
The principal unusual item is the issuance of special equity awards to named executive officers. The ultimate value and vesting of the performance-based RSUs depend on future company performance and targets that had not yet been disclosed in the filing.
Investor Verification Items
- Verify the specific 2027–2030 performance targets and vesting outcomes when disclosed.
- Assess the future stock-based compensation expense and potential dilution from the RSU grants.
- Review subsequent filings for amendments, forfeitures, or additional executive compensation arrangements.